Alivus Life Sciences Limited
NSE: ALIVUS · Healthcare
₹1,348.40
-17.70 (-1.30%)
Last close · 30 Aug 2026, 11:54 am IST
- Open
- ₹1,369.00
- Day high
- ₹1,370.00
- Day low
- ₹1,335.20
- Volume
- 33.4 K
- Prev close
- ₹1,366.10
HealthcareDrug Manufacturers - Specialty & GenericPart of:All NSE StocksNifty 500Nifty MidSmallcap 400Nifty Smallcap 250
Price chart
Range
EMA
Also show
Fundamentals
Drug Manufacturers - Specialty & Generic
Valuation
- Market Cap
- 13,516 Cr
- Price
- 1,101.20
- P/E (TTM)
- 23.98
- P/E (Fwd)
- 18.97
- P/B
- 4.06
- EV/EBITDA
- 16.07
- EV/Revenue
- 5.02
- PEG
- —
- Div Yield
- 0.45%
- 52W High
- 1,193.90
- 52W Low
- 819.00
- Beta
- 0.05
Profitability & income
- Revenue (TTM)
- 2,552 Cr
- Net Income (TTM)
- 564 Cr
- EBITDA
- 797 Cr
- Gross Margin
- 58.20%
- Op. Margin
- 28.20%
- Net Margin
- 22.12%
- ROE
- 18.36%
- ROA
- 12.20%
- EPS (TTM)
- 45.92
- EPS (Fwd)
- 58.04
Financial health
- Total Debt
- 57 Cr
- Total Cash
- 783 Cr
- Debt/Equity
- 1.70
- Current Ratio
- 5.22
- Quick Ratio
- 3.72
- Book Value
- 271.02
- Free Cash Flow
- 171 Cr
- Op. Cash Flow
- 565 Cr
Growth
- Revenue Growth
- 6.10%
- Earnings Growth
- 14.50%
- Earnings QoQ
- 14.70%
Quarterly results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 689 Cr | 163 Cr | 237 Cr | 194 Cr | 418 Cr | — | 57 Cr | 3,332 Cr |
| 2025-12-31 | 673 Cr | 150 Cr | 220 Cr | 212 Cr | 396 Cr | — | — | — |
| 2025-06-30 | 602 Cr | 122 Cr | 181 Cr | 155 Cr | 331 Cr | — | — | — |
| 2025-03-31 | 650 Cr | 142 Cr | 209 Cr | 182 Cr | 367 Cr | — | 57 Cr | 2,817 Cr |
| 2024-12-31 | 642 Cr | 137 Cr | 201 Cr | 175 Cr | 357 Cr | — | — | — |
Annual results
| Period | Revenue | Net Income | EBITDA | Op. Income | Gross Profit | Op. Cash Flow | Total Debt | Equity |
|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | 2,552 Cr | 564 Cr | 832 Cr | 722 Cr | 1,485 Cr | 565 Cr | 57 Cr | 3,332 Cr |
| 2025-03-31 | 2,387 Cr | 486 Cr | 717 Cr | 622 Cr | 1,306 Cr | 392 Cr | 57 Cr | 2,817 Cr |
| 2024-03-31 | 2,185 Cr | 471 Cr | 686 Cr | 622 Cr | 1,164 Cr | 414 Cr | 17 Cr | 2,332 Cr |
| 2023-03-31 | 2,048 Cr | 467 Cr | 671 Cr | 601 Cr | 1,016 Cr | 306 Cr | 19 Cr | 2,138 Cr |
| 2022-03-31 | — | — | — | — | — | — | — | — |
Figures in ₹ crore unless stated. Ratios and margins are trailing twelve months where marked TTM.
Want charts and signals for ALIVUS?
Sign in for candlestick charts with Supertrend, MACD and VWAP overlays, plus watchlists and email alerts.
Sign in